It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...
Broadcast Retirement Network's Jeffrey Snyder discusses the state of investment in the life sciences with scientist and ...
Eli Lilly stock prepares €15B Abivax acquisition as tirzepatide revenue hits $24.8B. Orforglipron oral weight loss drug ...
Ankita Vashistha launched Saha Fund in 2015, India’s first-ever VC fund dedicated entirely to women entrepreneurs. Today, ...
Driving Innovation Across Emerging Markets and Transformative Technologies ...
AZ Animals US on MSN
Frozen Genes or Final Days? Inside the Race to Rebuild a Species
An Instagram post about the last two northern white rhinos references a scenario conservationists have warned us about for ...
Arrowhead Pharmaceuticals has reported early-phase data on a pair of gene silencing drug candidates in obesity, posting ...
Summit Therapeutics has generated plenty of buzz in the biotech industry over the past two years. That's because the ...
The clinical-stage biotech could see its shares plummet should there be any clinical setback.
Aside from the layoffs, InflaRx will deprioritize Gohibic, a COVID-19 antibody that was granted emergency use authorization ...
Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...
Inovio’s upside hinges on INO-3107 for HPV-6/11 RRP with FDA PDUFA Oct 2026, regulatory risk, tight cash, and cheap EV. Check ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback